All News #Library
Others
Orionis Bio Appoints Dr. Giulio Draetta Chief Strategy Officer
01 Apr 2026 //
PHARMIWEB
ChemDiv Marks a Milestone as Orionis` Novel Immunotherapy Enters Ph I Trials
03 Jan 2024 //
PR NEWSWIRE
Orionis Biosciences Announces Collaboration with Genentech
20 Sep 2023 //
BUSINESSWIRE
Orionis Presents Data on Interferon and IL-2 Targeted Cytokine Immunotherapies
14 Nov 2022 //
BUSINESSWIRE

Market Place
Sourcing Support